BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11574404)

  • 21. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.
    Wang X; Zhou J; Doyle ME; Egan JM
    Endocrinology; 2001 May; 142(5):1820-7. PubMed ID: 11316746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling.
    Trümper A; Trümper K; Trusheim H; Arnold R; Göke B; Hörsch D
    Mol Endocrinol; 2001 Sep; 15(9):1559-70. PubMed ID: 11518806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell signalling of the GLP-1 action in rat liver.
    Redondo A; Trigo MV; Acitores A; Valverde I; Villanueva-Peñacarrillo ML
    Mol Cell Endocrinol; 2003 Jun; 204(1-2):43-50. PubMed ID: 12850280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
    Lee YS; Jun HS
    Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.
    Yusta B; Somwar R; Wang F; Munroe D; Grinstein S; Klip A; Drucker DJ
    J Biol Chem; 1999 Oct; 274(43):30459-67. PubMed ID: 10521425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of protein kinase C, PI3-kinase and tyrosine kinase in activation of MAP kinase by glucose and agonists of G-protein coupled receptors in INS-1 cells.
    Böcker D; Verspohl EJ
    Int J Exp Diabetes Res; 2001; 2(3):233-44. PubMed ID: 12369712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear mitogen-activated protein kinase activation by protein kinase czeta during reoxygenation after ischemic hypoxia.
    Mizukami Y; Kobayashi S; Uberall F; Hellbert K; Kobayashi N; Yoshida K
    J Biol Chem; 2000 Jun; 275(26):19921-7. PubMed ID: 10777509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1.
    Idris I; Patiag D; Gray S; Donnelly R
    Biochem Pharmacol; 2002 Mar; 63(5):993-6. PubMed ID: 11911852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways.
    MacDonald PE; Wang X; Xia F; El-kholy W; Targonsky ED; Tsushima RG; Wheeler MB
    J Biol Chem; 2003 Dec; 278(52):52446-53. PubMed ID: 14565957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway.
    Jimenez-Feltstrom J; Lundquist I; Salehi A
    Cell Tissue Res; 2005 Feb; 319(2):221-30. PubMed ID: 15558323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1.
    Bulotta A; Hui H; Anastasi E; Bertolotto C; Boros LG; Di Mario U; Perfetti R
    J Mol Endocrinol; 2002 Dec; 29(3):347-60. PubMed ID: 12459036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.
    Widmann C; Dolci W; Thorens B
    Mol Endocrinol; 1996 Jan; 10(1):62-75. PubMed ID: 8838146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1.
    Cousin SP; Hügl SR; Wrede CE; Kajio H; Myers MG; Rhodes CJ
    Endocrinology; 2001 Jan; 142(1):229-40. PubMed ID: 11145586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leptin constrains phospholipase C-protein kinase C-induced insulin secretion via a phosphatidylinositol 3-kinase-dependent pathway.
    Lee JW; Swick AG; Romsos DR
    Exp Biol Med (Maywood); 2003 Feb; 228(2):175-82. PubMed ID: 12563024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro.
    Bregenholt S; Møldrup A; Blume N; Karlsen AE; Nissen Friedrichsen B; Tornhave D; Knudsen LB; Petersen JS
    Biochem Biophys Res Commun; 2005 May; 330(2):577-84. PubMed ID: 15796922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.
    Egan JM; Bulotta A; Hui H; Perfetti R
    Diabetes Metab Res Rev; 2003; 19(2):115-23. PubMed ID: 12673779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic effect of dimethyl sulfoxide on glucagon-like peptide 1 (GLP-1)-stimulated insulin secretion and gene transcription in INS-1 cells: characterization and implications.
    Kemp DM; Habener JF
    Biochem Pharmacol; 2002 Aug; 64(4):689-97. PubMed ID: 12167488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Participation of protein kinases in the stimulant action of GLP-1 on 2-deoxy-D-glucose uptake by normal rat skeletal muscle.
    Acitores A; González N; Sancho V; Arnés L; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML
    Horm Metab Res; 2005 May; 37(5):275-80. PubMed ID: 15971149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose and glucoincretin peptides synergize to induce c-fos, c-jun, junB, zif-268, and nur-77 gene expression in pancreatic beta(INS-1) cells.
    Susini S; Roche E; Prentki M; Schlegel W
    FASEB J; 1998 Sep; 12(12):1173-82. PubMed ID: 9737720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.
    Farilla L; Hui H; Bertolotto C; Kang E; Bulotta A; Di Mario U; Perfetti R
    Endocrinology; 2002 Nov; 143(11):4397-408. PubMed ID: 12399437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.